Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

N Yu Mironov1, S P Golitsyn

  • 1Russian Cardiology Research Center. 7ko@gmail.com.

Kardiologiia
|January 10, 2019
PubMed
Summary
This summary is machine-generated.

This review covers key updates from the 2017 American Heart Association/American College of Cardiology/Heart Rhythm Society (AHA/ACC/HRS) guidelines on managing ventricular arrhythmias and preventing sudden cardiac death.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[New pathogenic mutation in LMNA gene: Clinical case of familial cardiomyopathy].

Terapevticheskii arkhiv·2025
Same author

Early initiation of anti-relapse antiarrhythmic therapy in patients with atrial fibrillation and flutter after pharmacological cardioversion with refralon.

Kardiologiia·2023
Same author

The Dependence of the Electrophysiological Effects of Class III Antiarrhythmic Drug Refralon on the Frequency of Myocardium Activation.

Bulletin of experimental biology and medicine·2023
Same author

[Left bundle branch block - dilated cardiomyopathy - heart failure: common links in the closed pathogenetic chain].

Kardiologiia·2023
Same author

[Recent advances in diagnosis and management of atrial fibrillation].

Terapevticheskii arkhiv·2022
Same author

[Efficiency and safety of using the modified protocol for the administration of the domestic class III antiarrhythmic drug for the relief of paroxysmal atrial fibrillation].

Terapevticheskii arkhiv·2022
Same journal

[Clinical Case of Using Inclisiran in a Patient with End-Stage Renal Disease, Before and After Kidney Transplantation].

Kardiologiia·2026
Same journal

Cardiometabolic and Antioxidant Properties of Modified C-Terminal Fragments of Apelin in Experimental Cardiac Pathology.

Kardiologiia·2026
Same journal

Peroxisome Biogenesis Factor 10 Upregulation Promotes Cardiomyocyte Ferroptosis and Glutathione Peroxidase 4 Repression During Myocardial Ischemia-Reperfusion Injury.

Kardiologiia·2026
Same journal

Diagnostic Value and Prognostic Assessment of Exercise Stress Echocardiography in Patients With Suspected Coronary Artery Disease Without Typical Angina Symptoms.

Kardiologiia·2026
Same journal

Early Post-discharge Glycemic Control and Cardiovascular Event Readmission in Patients With Heart Failure and Type 2 Diabetes: A Single-center Retrospective Cohort Study.

Kardiologiia·2026
Same journal

Microcirculatory Features of the Conjunctiva and Retina in Patients with Stable Ischemic Heart Disease and Various Patterns of Coronary Artery Involvement.

Kardiologiia·2026
See all related articles

Area of Science:

  • Cardiology
  • Electrophysiology
  • Public Health

Background:

  • Ventricular arrhythmias pose a significant risk for sudden cardiac death.
  • Established guidelines are crucial for effective patient management.
  • The 2017 AHA/ACC/HRS guidelines represent a significant update in the field.

Purpose of the Study:

  • To summarize major updates in the 2017 AHA/ACC/HRS guideline.
  • To highlight key points for managing patients with ventricular arrhythmias.
  • To review strategies for the prevention of sudden cardiac death.

Main Methods:

  • Review of the 2017 AHA/ACC/HRS guideline document.
  • Focus on significant revisions and recommendations.
  • Synthesis of information for clinical application.

Related Experiment Videos

Main Results:

  • The 2017 guideline incorporates new evidence and therapeutic approaches.
  • Specific recommendations address risk stratification and treatment modalities.
  • Emphasis on personalized management strategies for ventricular arrhythmias.

Conclusions:

  • Adherence to the updated 2017 AHA/ACC/HRS guidelines is essential for optimal care.
  • These guidelines aim to improve outcomes for patients at risk of sudden cardiac death.
  • Continuous education on guideline updates is vital for healthcare professionals.